Can the Neupro (rotigotine) transdermal patch be continued during anesthesia and surgery, and what peri‑operative management is recommended?

Neupro (Rotigotine) Perioperative Management

The Neupro transdermal patch should be removed before undergoing anesthesia and surgery, particularly before MRI or cardioversion procedures, and must be removed if the surgical site will be exposed to forced hot-air warming devices.

Critical Safety Requirement: Patch Removal Before Certain Procedures

• Neupro must be removed before magnetic resonance imaging (MRI) or cardioversion due to risk of burns at the application site 1
• The patch should be removed if the application site will be under forced hot-air warming devices intraoperatively, as heat exposure significantly increases drug absorption and can alter the patch's duration of effectiveness 2

General Perioperative Management Strategy

For most surgical procedures, Neupro can be continued perioperatively based on available evidence and the unique advantages of transdermal delivery:

• Rotigotine transdermal patch provides stable 24-hour plasma concentrations, allowing continuous dopaminergic stimulation throughout the perioperative period 3, 4
• In a retrospective analysis of 61 surgical interventions in 52 patients with restless legs syndrome, rotigotine dosing was maintained during 95% of perioperative periods, with only temporary suspension in one patient and permanent discontinuation in two others 3
• A case series of 14 Parkinson's disease patients undergoing general anesthesia found that rotigotine (median dose 12 mg/24 h) was considered feasible by patients, anesthesiologists, and neurologists with good symptom control 4

Specific Perioperative Considerations

When to Continue the Patch

• Continue rotigotine if the surgical site does not require forced hot-air warming and the patch location can be maintained away from the operative field 2, 3
• The transdermal route bypasses gastrointestinal absorption issues, making it particularly advantageous when oral medication administration is problematic perioperatively 5, 6
• Rotigotine has been successfully used to treat akinetic crisis in patients unable to take oral medications, demonstrating its utility in acute perioperative situations 7

Patch Location Management

• Apply the patch to a site that will not be under the surgical drape or forced hot-air warmer (abdomen, thigh, hip, flank, shoulder, or upper arm) 1
• If the current patch location will be affected by surgery or warming devices, remove it and apply a new patch to an alternative site immediately preoperatively 2
• Ensure the new application site has not been used within the previous 14 days 1

Heat Exposure Precautions

• Avoid placing forced hot-air warmers over the patch site, as this significantly increases fentanyl release per unit time (similar concerns apply to rotigotine) 2
• If unavoidable, remove the patch and reapply to a different location outside the warming field 2
• Direct sun exposure to the patch should also be avoided, particularly if there is skin irritation 1

Abrupt Discontinuation Risks

Do not abruptly discontinue Neupro without medical supervision due to serious withdrawal complications:

• Sudden discontinuation can cause withdrawal-emergent hyperpyrexia and confusion, characterized by fever, muscular rigidity, and altered consciousness 1
• Withdrawal symptoms may include apathy, anxiety, depression, fatigue, insomnia, sweating, or pain 1
• If severe withdrawal symptoms occur, re-administration of a dopamine agonist at the lowest effective dose may be necessary 1

Practical Perioperative Algorithm

1. Preoperative assessment: Identify patch location and planned surgical site/warming device placement 2
2. For MRI/cardioversion: Remove patch before procedure 1
3. For other surgeries with potential heat exposure: Remove and reapply to alternative site if necessary 2
4. For surgeries without heat exposure concerns: Continue patch at current site if away from operative field 3, 4
5. Postoperatively: Resume or continue patch at usual schedule, ensuring proper site rotation 1

Common Pitfalls to Avoid

• Never cut or damage the patch, as this alters drug delivery 1
• Do not apply heat sources (heating pads, saunas, hot baths) to the patch area perioperatively 1
• Avoid abrupt discontinuation without a tapering plan and medical supervision 1
• Do not forget to document patch location and management plan in the anesthetic record 2